Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience
Open Access
- 19 November 2009
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 17 (3), 686-693
- https://doi.org/10.1245/s10434-009-0806-9
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Histopathological Diagnostic Discrepancies in Soft Tissue Tumours Referred to a Specialist CentreSarcoma, 2009
- Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysisLaboratory Investigation, 2009
- Effectiveness of Radiotherapy in Myxoid Sarcomas Is Associated With a Dense Vascular PatternInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Irradiation of myxoid/round cell liposarcoma induces volume reduction and lipoma-like morphologyActa Oncologica, 2007
- Differential sensitivity of liposarcoma subtypes to chemotherapyEuropean Journal Of Cancer, 2005
- Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevanceEuropean Journal of Surgical Oncology, 2004
- Pleomorphic Liposarcoma: Clinicopathologic, Immunohistochemical, and Follow-up Analysis of 63 CasesThe American Journal of Surgical Pathology, 2002
- Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patientsEuropean Journal of Surgical Oncology, 2001
- A Novel FUS/CHOP Chimera in Myxoid LiposarcomaBiochemical and Biophysical Research Communications, 2000
- Variable management of soft tissue sarcoma: Regional audit with implications for specialist careBritish Journal of Surgery, 1997